P733: TREATMENT PATTERNS AND OUTCOMES AMONG PATIENTS WITH LOWER-RISK MYELODYSPLASTIC SYNDROMES RECEIVING LUSPATERCEPT IN ROUTINE CLINICAL PRACTICE IN THE UNITED STATES
Sudipto Mukherjee,
Cherrishe Brown-Bickerstaff,
David Huggar,
Angelica Falkenstein,
Adeola Y. Makinde,
Emily Bland,
Jalyna Laney,
Marné Garretson,
Ali Mcbride
Affiliations
Sudipto Mukherjee
1 Cleveland Clinic, Cleveland, OH, United States
Cherrishe Brown-Bickerstaff
2 Cardinal Health Specialty Solutions, Dublin, OH, United States
David Huggar
3 Bristol Myers Squibb, Princeton, NJ, United States
Angelica Falkenstein
2 Cardinal Health Specialty Solutions, Dublin, OH, United States
Adeola Y. Makinde
4 Bristol Myers Squibb, Princeton, NJ, United States
Emily Bland
2 Cardinal Health Specialty Solutions, Dublin, OH, United States
Jalyna Laney
2 Cardinal Health Specialty Solutions, Dublin, OH, United States
Marné Garretson
2 Cardinal Health Specialty Solutions, Dublin, OH, United States
Ali Mcbride
3 Bristol Myers Squibb, Princeton, NJ, United States
